PortfoliosLab logo
APLT vs. MRUS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between APLT and MRUS is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

APLT vs. MRUS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Applied Therapeutics, Inc. (APLT) and Merus N.V. (MRUS). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

APLT:

63.06%

MRUS:

118.16%

Max Drawdown

APLT:

-8.09%

MRUS:

-9.06%

Current Drawdown

APLT:

-8.09%

MRUS:

-5.67%

Fundamentals

Market Cap

APLT:

$56.59M

MRUS:

$2.83B

EPS

APLT:

-$0.76

MRUS:

-$3.35

PS Ratio

APLT:

124.37

MRUS:

78.34

PB Ratio

APLT:

1.04

MRUS:

4.21

Total Revenue (TTM)

APLT:

$266.00K

MRUS:

$37.38M

Gross Profit (TTM)

APLT:

$144.00K

MRUS:

$37.38M

EBITDA (TTM)

APLT:

-$83.02M

MRUS:

-$331.91M

Returns By Period


APLT

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

MRUS

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

APLT vs. MRUS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

APLT
The Risk-Adjusted Performance Rank of APLT is 88
Overall Rank
The Sharpe Ratio Rank of APLT is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of APLT is 88
Sortino Ratio Rank
The Omega Ratio Rank of APLT is 66
Omega Ratio Rank
The Calmar Ratio Rank of APLT is 22
Calmar Ratio Rank
The Martin Ratio Rank of APLT is 88
Martin Ratio Rank

MRUS
The Risk-Adjusted Performance Rank of MRUS is 3636
Overall Rank
The Sharpe Ratio Rank of MRUS is 4444
Sharpe Ratio Rank
The Sortino Ratio Rank of MRUS is 3636
Sortino Ratio Rank
The Omega Ratio Rank of MRUS is 3636
Omega Ratio Rank
The Calmar Ratio Rank of MRUS is 2727
Calmar Ratio Rank
The Martin Ratio Rank of MRUS is 3535
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

APLT vs. MRUS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Applied Therapeutics, Inc. (APLT) and Merus N.V. (MRUS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

APLT vs. MRUS - Dividend Comparison

Neither APLT nor MRUS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

APLT vs. MRUS - Drawdown Comparison

The maximum APLT drawdown since its inception was -8.09%, smaller than the maximum MRUS drawdown of -9.06%. Use the drawdown chart below to compare losses from any high point for APLT and MRUS. For additional features, visit the drawdowns tool.


Loading data...

Volatility

APLT vs. MRUS - Volatility Comparison


Loading data...

Financials

APLT vs. MRUS - Financials Comparison

This section allows you to compare key financial metrics between Applied Therapeutics, Inc. and Merus N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M202120222023202420250
9.14M
(APLT) Total Revenue
(MRUS) Total Revenue
Values in USD except per share items